Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 50 Prostatic Neoplasms 44 Multiple Myeloma 22 Neoplasm Metastasis 17 Osteoporosis 14 Pain 11 Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasms, Plasma Cell 5 Lung Neoplasms 5 Bone Diseases, Metabolic 5 Fractures, Bone 4 Bone Diseases 4 Lymphoma 3 Carcinoma, Renal Cell 3 Bone Neoplasms 3 Spinal Cord Compression 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neuroblastoma 2 Kidney Neoplasms 2 Humoral Hypercalcemia Of Malignancy 2 Triple Negative Breast Neoplasms 1 Treatment of Bone Metastases 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Insufficiency 1 Recurrence 1 Pleural Effusion, Malignant 1

Interventions

Doxorubicin 13 Gemcitabine 10 Ifosfamide 9 Trabectedin 7 Radiotherapy 7 Docetaxel 5 Dacarbazine 5 pazopanib 3 Sunitinib 3 Sorafenib 3 Nivolumab 3 Filgrastim 3 pembrolizumab 2 pegfilgrastim 2 liposomal doxorubicin 2 eribulin 2 cixutumumab 2 belinostat 2 Radiotherapy, Conformal 2 Imatinib Mesylate 2 Chemotherapy, Adjuvant 2 Bevacizumab 2 tremelimumab 1 temsirolimus 1 soblidotin 1 selinexor 1 sargramostim 1 saracatinib 1 rubitecan 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leiomyosarcoma × Zoledronic Acid × Clear all

NCT05080790 2025-08-17

DiTuSarc

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡